title: [Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma].
abstract: A 51-year-old male was assessed as having esophageal squamous cell carcinoma with trachea invasion and cervical lymph node metastasis. After one course of chemotherapy using cisplatin (CDDP), 5-fluorouracil (5-FU) and Leucovorin (LV), the patient had progressive disease (PD) of the primary lesion and metastatic lymph nodes, and a side effect of severe nausea. One course of nedaplatin, 5-FU and LV combined with radiation was performed alternatively. The effect was evaluated as a partial response (PR) of the primary lesion and metastatic lymph nodes. There were no adverse side effects such as nausea or renal dysfunction except for pancytopenia of grade 2. Increased serum levels of vascular endothelial growth factor (s-VEGF) decreased after the chemoradiotherapy and increased again during continued radiotherapy alone. More information is needed as to whether changes in s-VEGF relate to the clinical effects of the treatment.
authors.affiliation: Dept. of Surgery I, Nippon Medical School.
authors.forename: Ryouhei
authors.initials: R
authors.lastname: Futami
authors.forename: Takashi
authors.initials: T
authors.lastname: Tajiri
authors.forename: Masao
authors.initials: M
authors.lastname: Miyashita
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Maruyama
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Makino
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Nomura
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tateno
authors.forename: Tsuguhiro
authors.initials: T
authors.lastname: Miyashita
authors.forename: Koji
authors.initials: K
authors.lastname: Sasajima
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy* / Q000556:secondary; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D016228:Endothelial Growth Factors / Q000097:blood; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood; D002955:Leucovorin / Q000008:administration & dosage; D008207:Lymphatic Metastasis; D008222:Lymphokines / Q000097:blood; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D014134:Tracheal Neoplasms / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D009944:Organoplatinum Compounds; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C053989:nedaplatin; D002955:Leucovorin; D005472:Fluorouracil